{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-074574","form_type":"8-K","ticker":"RIGL","cik":"0001034842","company_name":"RIGEL PHARMACEUTICALS INC","filed_at":"2024-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.955902+00:00","generated_at":"2026-06-01T02:04:09.450230+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rigel Pharmaceuticals announces 1-for-10 reverse stock split effective June 27, 2024","bullets":["Reverse stock split at 1-for-10 ratio, reducing shares from ~175.6M to ~17.6M.","Effective June 27, 2024 at 12:01 a.m. ET; trading begins on split-adjusted basis same day.","Board approved final ratio on June 15, 2024, following stockholder approval on May 24, 2024.","Primary goal: raise per-share price to improve marketability and maintain Nasdaq $1 minimum bid compliance.","No fractional shares; cash in lieu paid. Authorized shares and par value unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-074574","json":"https://secwatch.observer/filing/0001104659-24-074574.json","markdown":"https://secwatch.observer/filing/0001104659-24-074574.md","text":"https://secwatch.observer/filing/0001104659-24-074574.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1034842/000110465924074574/0001104659-24-074574-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1034842/000110465924074574/tm2417992d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:04:09.450230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}